Cointime

Longevity Vision Fund

company

About

Longevity Vision Fund invests in technologies that have the potential to disrupt life sciences and extend healthy lifespan.

  • 1 - 10

Highlights

Investments
4

Details

Industries
Biotechnology,Finance,Life Science
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
Venture Capital

Longevity Vision Fund is a $100M investment fund dedicated to making longevity affordable and accessible to all. The fund accelerates longevity breakthroughs by investing in companies that develop technologies, products, and services that extend healthy human lifespans and overcome the negative effects of aging

Longevity Vision Fund provides Seed to Series C funding to biotech and life extension-focused companies that have demonstrated affordable longevity potential and vision of milestones driving up the value of the company and market validation.

Investments

Number of Investments
Number of Lead Investments
4
0
Longevity Vision Fund has made 4 investments. Their most recent investment was on Apr 19, 2022, when Tessera Therapeutics raised $300M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 19, 2022 Tessera Therapeutics
Series C $300M Biopharma —
Jan 12, 2021 Tessera Therapeutics
Series B $230M Biopharma —
Nov 9, 2020 Eko
Series C $65M Artificial Intelligence —
Jul 24, 2019 Freenome
Series B $160M Biotechnology —
Cointime
Содержание
компания